SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Ehsaan Akhtar, Vignan Manne, Sammy Saab, Cirrhosis regression in hepatitis C patients with sustained virological response after antiviral therapy: a meta-analysis, Liver International, 2014, 34, 6
  2. 2
    Carla Krueger, Mark Collister, Gerald Y. Minuk, Alyssa Janke, Jordyn Lerner, Stephen G. M. Wong, Julia D. Rempel, HCV protein-induced cytokine predicts treatment outcomes in chronic hepatitis C virus infection, Liver International, 2014, 34, 6
  3. 3
    Mitchell L. Shiffman, Hepatitis C virus therapy in the direct acting antiviral era, Current Opinion in Gastroenterology, 2014, 30, 3, 217

    CrossRef

  4. You have free access to this content4
    Vincenzo Boccaccio, Savino Bruno, Management of HCV patients with cirrhosis with direct acting antivirals, Liver International, 2014, 34,
  5. 5
    John M. Vierling, Stefan Zeuzem, Fred Poordad, Jean-Pierre Bronowicki, Michael P. Manns, Bruce R. Bacon, Rafael Esteban, Steven L. Flamm, Paul Y. Kwo, Lisa D. Pedicone, Weiping Deng, Frank J. Dutko, Mark J. DiNubile, Kenneth J. Koury, Frans A. Helmond, Janice Wahl, Savino Bruno, Safety and efficacy of boceprevir/peginterferon/ribavirin for HCV G1 compensated cirrhotics: Meta-analysis of 5 trials, Journal of Hepatology, 2014,

    CrossRef

  6. 6
    A. J. Meer, B. J. Veldt, J. J. Feld, H. Wedemeyer, J.-F. Dufour, F. Lammert, A. Duarte-Rojo, M. P. Manns, S. Zeuzem, W. P. Hofmann, R. J. Knegt, B. E. Hansen, H. L. A. Janssen, The number needed to treat to prevent mortality and cirrhosis-related complications among patients with cirrhosis and HCV genotype 1 infection, Journal of Viral Hepatitis, 2014, 21, 8
  7. 7
    Nasser Ebrahimi Daryani, Seyed Moayed Alavian, Mohammad Hossein Somi, Mohammad Torabi-Nami, Hepatitis C and Why the Treatment is Needed Now? The Summary Report From the Cross-Border Symposium of the 5th Tehran Hepatitis Congress May 2013, Hepatitis Monthly, 2013, 13, 11

    CrossRef

  8. 8
    Roberta D’Ambrosio, Massimo Colombo, Safety of direct antiviral agents in real life, Digestive and Liver Disease, 2013, 45, S363

    CrossRef

  9. 9
    Maribel Rodríguez-Torres, Sofosbuvir (GS-7977), a pan-genotype, direct-acting antiviral for hepatitis C virus infection, Expert Review of Anti-infective Therapy, 2013, 11, 12, 1269

    CrossRef

  10. 10
    Eric Lawitz, Alessandra Mangia, David Wyles, Maribel Rodriguez-Torres, Tarek Hassanein, Stuart C. Gordon, Michael Schultz, Mitchell N. Davis, Zeid Kayali, K. Rajender Reddy, Ira M. Jacobson, Kris V. Kowdley, Lisa Nyberg, G. Mani Subramanian, Robert H. Hyland, Sarah Arterburn, Deyuan Jiang, John McNally, Diana Brainard, William T. Symonds, John G. McHutchison, Aasim M. Sheikh, Zobair Younossi, Edward J. Gane, Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection, New England Journal of Medicine, 2013, 368, 20, 1878

    CrossRef

  11. 11
    Paul M. Trembling, Sudeep Tanwar, William M. Rosenberg, Geoffrey M. Dusheiko, Treatment decisions and contemporary versus pending treatments for hepatitis C, Nature Reviews Gastroenterology & Hepatology, 2013, 10, 12, 713

    CrossRef